Tizona Therapeutics
Improving outcomes for people with cancer
- Headquarters
- California
- Business Model
- B2B
- Website
- tizonatx.com
- Total Funding
- $370.0M
- Last Round
- $300.0M Corporate RoundJul 2020
- Rounds
- 3
About
Clinical-stage oncology company developing first-in-class cancer immunotherapy treatments targeting immune checkpoint pathways.
Summary
Tizona Therapeutics is a Biotech company based in United States. It has raised $370.0M in total across 3 rounds, most recently a $300.0M Corporate Round round in Jul 2020. Investors include Gilead Sciences, Abingworth and Canaan Partners.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...